Comment: Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of pharmacotherapy 2006-06, Vol.40 (6), p.1215-1216
1. Verfasser: Shannon, Caitlin S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1216
container_issue 6
container_start_page 1215
container_title The Annals of pharmacotherapy
container_volume 40
creator Shannon, Caitlin S
description
doi_str_mv 10.1345/aph.1G481d
format Article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1345_aph_1G481d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1345_aph.1G481d</sage_id><sourcerecordid>10.1345_aph.1G481d</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-32514d0b41e620e0ecd31baa115b9bf1ac92431f81cb38ac8f5b3bcc43e43eb53</originalsourceid><addsrcrecordid>eNptkFFLwzAQx4Mobk5f_ACSN0HozDVN1_pWypzCRFD3XJL04jrWZiTdYN_eSAe-CAf_g_vdcfwIuQU2BZ6IR7lbT2GRZFCfkTGIJI7SeMbOQ89SFrE4YyNy5f2GMZZDnF-SEaQzLlKRjYksbdti1z_RopPbo288tYZ-4gEd0qIO4ZHOD4Hw9AO3ssea9pb2a6SrMAnsW2Nw5xrf2w6p9FR2tFDW9Y2Rugl71-TCyK3Hm1NOyOp5_lW-RMv3xWtZLCPNYdZHPBaQ1EwlgGnMkKGuOSgpAYTKlQGp8zjhYDLQimdSZ0YorrROOIZSgk_Iw3BXO-u9Q1OFr1rpjhWw6tdTFTxVg6cA3w3wbq9arP_Qk5gA3A-Al99YbezeBT3-v1M_VZNxUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comment: Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Shannon, Caitlin S</creator><creatorcontrib>Shannon, Caitlin S</creatorcontrib><identifier>ISSN: 1060-0280</identifier><identifier>EISSN: 1542-6270</identifier><identifier>DOI: 10.1345/aph.1G481d</identifier><identifier>PMID: 16735658</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Abnormalities, Drug-Induced - epidemiology ; Abortifacient Agents, Steroidal - adverse effects ; Adult ; Female ; Humans ; Mifepristone - adverse effects ; Mobius Syndrome - chemically induced ; Pregnancy ; Pregnancy Outcome ; United States - epidemiology ; United States Food and Drug Administration</subject><ispartof>The Annals of pharmacotherapy, 2006-06, Vol.40 (6), p.1215-1216</ispartof><rights>Copyright © 2006 Harvey Whitney Books Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-32514d0b41e620e0ecd31baa115b9bf1ac92431f81cb38ac8f5b3bcc43e43eb53</citedby><cites>FETCH-LOGICAL-c317t-32514d0b41e620e0ecd31baa115b9bf1ac92431f81cb38ac8f5b3bcc43e43eb53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1345/aph.1G481d$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1345/aph.1G481d$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21818,27923,27924,43620,43621</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16735658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shannon, Caitlin S</creatorcontrib><title>Comment: Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient</title><title>The Annals of pharmacotherapy</title><addtitle>Ann Pharmacother</addtitle><subject>Abnormalities, Drug-Induced - epidemiology</subject><subject>Abortifacient Agents, Steroidal - adverse effects</subject><subject>Adult</subject><subject>Female</subject><subject>Humans</subject><subject>Mifepristone - adverse effects</subject><subject>Mobius Syndrome - chemically induced</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>United States - epidemiology</subject><subject>United States Food and Drug Administration</subject><issn>1060-0280</issn><issn>1542-6270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkFFLwzAQx4Mobk5f_ACSN0HozDVN1_pWypzCRFD3XJL04jrWZiTdYN_eSAe-CAf_g_vdcfwIuQU2BZ6IR7lbT2GRZFCfkTGIJI7SeMbOQ89SFrE4YyNy5f2GMZZDnF-SEaQzLlKRjYksbdti1z_RopPbo288tYZ-4gEd0qIO4ZHOD4Hw9AO3ssea9pb2a6SrMAnsW2Nw5xrf2w6p9FR2tFDW9Y2Rugl71-TCyK3Hm1NOyOp5_lW-RMv3xWtZLCPNYdZHPBaQ1EwlgGnMkKGuOSgpAYTKlQGp8zjhYDLQimdSZ0YorrROOIZSgk_Iw3BXO-u9Q1OFr1rpjhWw6tdTFTxVg6cA3w3wbq9arP_Qk5gA3A-Al99YbezeBT3-v1M_VZNxUQ</recordid><startdate>200606</startdate><enddate>200606</enddate><creator>Shannon, Caitlin S</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200606</creationdate><title>Comment: Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient</title><author>Shannon, Caitlin S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-32514d0b41e620e0ecd31baa115b9bf1ac92431f81cb38ac8f5b3bcc43e43eb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Abnormalities, Drug-Induced - epidemiology</topic><topic>Abortifacient Agents, Steroidal - adverse effects</topic><topic>Adult</topic><topic>Female</topic><topic>Humans</topic><topic>Mifepristone - adverse effects</topic><topic>Mobius Syndrome - chemically induced</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>United States - epidemiology</topic><topic>United States Food and Drug Administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shannon, Caitlin S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The Annals of pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shannon, Caitlin S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comment: Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient</atitle><jtitle>The Annals of pharmacotherapy</jtitle><addtitle>Ann Pharmacother</addtitle><date>2006-06</date><risdate>2006</risdate><volume>40</volume><issue>6</issue><spage>1215</spage><epage>1216</epage><pages>1215-1216</pages><issn>1060-0280</issn><eissn>1542-6270</eissn><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>16735658</pmid><doi>10.1345/aph.1G481d</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1060-0280
ispartof The Annals of pharmacotherapy, 2006-06, Vol.40 (6), p.1215-1216
issn 1060-0280
1542-6270
language eng
recordid cdi_crossref_primary_10_1345_aph_1G481d
source MEDLINE; SAGE Complete A-Z List
subjects Abnormalities, Drug-Induced - epidemiology
Abortifacient Agents, Steroidal - adverse effects
Adult
Female
Humans
Mifepristone - adverse effects
Mobius Syndrome - chemically induced
Pregnancy
Pregnancy Outcome
United States - epidemiology
United States Food and Drug Administration
title Comment: Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A16%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comment:%20Analysis%20of%20Severe%20Adverse%20Events%20Related%20to%20the%20Use%20of%20Mifepristone%20as%20an%20Abortifacient&rft.jtitle=The%20Annals%20of%20pharmacotherapy&rft.au=Shannon,%20Caitlin%20S&rft.date=2006-06&rft.volume=40&rft.issue=6&rft.spage=1215&rft.epage=1216&rft.pages=1215-1216&rft.issn=1060-0280&rft.eissn=1542-6270&rft_id=info:doi/10.1345/aph.1G481d&rft_dat=%3Csage_cross%3E10.1345_aph.1G481d%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16735658&rft_sage_id=10.1345_aph.1G481d&rfr_iscdi=true